Delivery Order SPE2DB22D1200-SPE2DB25FN2CS

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg Dextroamphetamine-Amphetamine capsules, a pharmaceutical product, with a ceiling value of $2,358.04. The contract is a firm fixed-price, non-set-aside award with a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is for the delivery of 4,568,135,213 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10 mg Dextroamphetamine-Amphetamine capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,763.85 and a period of performance through April 2025. There is no set-aside designation, indicating the order was competed openly. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical products including Dextroamphetamine-Amphetamine 30 mg capsules. The contract has a ceiling value of $3,004.85 and a performance period extending through April 16, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,857.79 firm-fixed-price contract is for the delivery of 20 mg dextroamphetamine-amphetamine capsules. The order has a completion date of May 20, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,550 units of Dextroamphetamine-amphetamine 30 mg capsules. The contract has a ceiling value of $2,099.13 and an ultimate completion date of August 23, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,019,039 units of the prescription medication dextroamphetamine-amphetamine 15 mg capsules, with a ceiling value of $1,528.00. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is a firm fixed-price, non-set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,734.75, is for the supply of 4,567,861,597 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,549 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with a ceiling value of $2,525.52 and a performance period extending through April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dextroamphetamine-Amphetamine 10 mg capsules, a type of prescription medication. The contract has a ceiling value of $1,631.82 and a period of performance through April 11, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN2CS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dextroamphetamine-Amphetamine 10mg capsules, with a ceiling value of $1,308.48 and a completion date of May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard, among others.

Generated 8/21/25, 9:56 AM